http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2785185-C

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c5ad2fe04ce35b5e58d8eb15acd5079
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-191
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-56
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04
filingDate 2011-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75f7fd267b9d64cf635b5c08b4b0c644
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_677e6eeeee1e2e5c9c431851f66261e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5082ac682a49043d858beef92f69718
publicationDate 2019-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2785185-C
titleOfInvention Organic compounds for the regulation of vectorial ion channels
abstract A cyclic organic compound which comprises 16 amino acids or 17 amino acids and has no carboxyl group C-terminally and/or no amino group N-terminally, wherein, optionally, one of the amino acids is a nonnatural amino acid, and wherein the ring closure is formed between a side chain of one amino acid and the C-terminus of another amino acid, or the ring closure is effected with the aid of a nonnatural amino acid, a process for its production and its use for the regulation of vectorial ion channels, for the treatment of diseases associated with the lung function and for the treatment of oedemas.
priorityDate 2010-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16231
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457586576
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450290983
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44450050
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID824
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13580
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414138017
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419540167
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID638112
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23666501
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487869
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6992101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505358
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486041
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6262
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426340625
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID564
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419511045
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413496829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527499

Total number of triples: 52.